106 results
Page 5 of 6
6-K
EX-1.1
w2nxvxf0
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
0qk1i690y4gda5w
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
w7nedril660zqrh0d
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
ka8j7o2hzg
8 Aug 13
Prospectus supplement
12:00am
424B5
2zxn fk9h
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
m0lnwm040rwth
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
77oqxri1q4j5ps
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
ugyun zhtoc
15 Oct 12
Prospectus supplement
12:00am
F-1
k0x74 q5spbz4h
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
z9xn0 zwftp
27 Sep 12
Current report (foreign)
12:00am
424B3
1qa98qlhxz7702va
2 Aug 12
Prospectus supplement
12:00am
F-3
106bcl8ct87
1 Aug 12
Shelf registration (foreign)
12:00am
POS AM
webyl7dc ee
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
x6x9 3rnk
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
akg2fg35e y1f9zmti
28 Mar 12
Prospectus supplement
12:00am
20-F
EX-12.1
wdcul1gb
22 Mar 12
Annual report (foreign)
12:00am
20-F
EX-12.2
vswvmdfetlnxgbiwy
22 Mar 12
Annual report (foreign)
12:00am